AIDS TREATMENT NEWS OUTREACH ASSISTANCE REQUESTED
Since early this year we have been aware and concerned thatmany people who could benefit from the information in AIDS
TREATMENT NEWS do not have access to it. In June we began
developing an outreach campaign in order to reach a larger
audience of HIV-impacted populations with our treatment message,
and now we request your assistance with this project. As one of
our subscribers, you can be part of our support structure and
help us succeed in our overall mission of getting the word out
about important treatment options and public policy issues.
The staff of AIDS TREATMENT NEWS is requesting the
assistance of our subscribers in the following outreach areas:
* New 800 subscription number. Help us spread the word that
interested parties can now call 1-800-TREAT-1-2 (1-800-873-2812)
for AIDS TREATMENT NEWS subscription information (Note: this is
not a treatment information hotline). Ask your local community
AIDS service organizations, HIV testing and counseling centers,
buyers' clubs, publications, bulletin boards, universities, etc.,
to update their AIDS resource lists to include this new number.
Our 800 number is currently valid in the 48 contiguous
United States and in Canada. The correct number for local San
Francisco calls, for other geographic areas, and for all non-
subscription business is 415/255-0588. Help us make sure that
our current numbers are listed in appropriate places in your
community, and listed accurately.
* Medical professionals, libraries, friends. Does your
doctor or other health professional, your HMO or medical center,
subscribe to AIDS TREATMENT NEWS? What about your local public
library, or college or university library, or the human resources
department where you work? Do you have friends or loved ones who
would benefit from the information in AIDS TREATMENT NEWS? Please
use the three coupons on the last page of this issue of the
newsletter to encourage others to subscribe. Remember that we
support our work almost exclusively through subscriptions; in
order to maintain complete editorial independence, we accept no
advertising.
* Special Assistance Fund. Although we offer a substantial
60 percent discount on subscriptions "for persons with AIDS/HIV
with financial difficulties" (and as many as 70 percent of our
subscribers use that rate at one time or another), the reality is
that many subscribers reach a point at which they can no longer
afford even the discounted price. Our policy has always been to
extend such subscriptions without charge in order to continue the
dissemination of valuable treatment information to persons living
with AIDS, struggling community-based organizations, prisoners
without resources, health departments in a budget crunch, etc.,
and we do not want to change that policy. However, the need
continues to grow faster than we have been able to generate
full-rate subscriptions which subsidize these free extensions.
We have established a Special Assistance Fund for those who
want to support our "free extension" program. We are asking for
donations of $20 (equivalent to one six-month extension) and $40
(equivalent to one 12-month extension or two six-month
extensions), or multiples thereof. We will track this income
separately, and make the information about revenue generated for
this fund available to any of our subscribers who request it.
AIDS TREATMENT NEWS is not a 501(c)(3) non-profit organization
for which donations are tax-deductible; editor/publisher John S.
James operates as a sole proprietor. However, we bring a strong
not-for-profit consciousness to our work -- we are working to
save lives, not in business to make money -- and we hope that you
will support this worthwhile program so we are not forced to
change our policy.
We would like to take this opportunity to thank all of our
subscribers who have sent unsolicited contributions to us in the
past. These donations have helped tremendously in allowing AIDS
TREATMENT NEWS to continue our "free extension" program to this
point.
STATEMENT OF PURPOSE
AIDS TREATMENT NEWS reports on experimental and complementary
treatments, especially those available now. It collects
information from medical journals, and from interviews with
scientists, physicians, and other health practitioners, and
persons with AIDS or HIV.
Long-term survivors have usually tried many different treatments,
and found combinations which work for them. AIDS TREATMENT NEWS
does not recommend particular therapies, but seeks to increase
the options available.
We also examine the ethical and public-policy issues around AIDS
treatment research and treatment access.
source: AIDS Treatment News




